Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Volker Vetter, Robert C. Gardner, Serge Debrus, Bernd Benninghoff & Priya Pereira. (2022) Established and new rotavirus vaccines: a comprehensive review for healthcare professionals. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Priya Pereira, Volker Vetter, Baudouin Standaert & Bernd Benninghoff. (2020) Fifteen years of experience with the oral live-attenuated human rotavirus vaccine: reflections on lessons learned. Expert Review of Vaccines 19:8, pages 755-769.
Read now
Read now
Ki Hwan Kim, Chun Soo Kim, Hwang Min Kim, Jong-Duck Kim, Sang Hyuk Ma, Dong Ho Kim, Pyoung-Han Hwang, Ji-Whan Han, Taek-Jin Lee, Joon Hyung Kim, Naveen Karkada, Narcisa Mesaros, Woo-Yun Sohn & Jong-Hyun Kim. (2019) Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study. Human Vaccines & Immunotherapeutics 15:2, pages 317-326.
Read now
Read now
Xi Jiang, Yang Liu & Ming Tan. (2017) Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy. Emerging Microbes & Infections 6:1, pages 1-8.
Read now
Read now
Zenas Kuate Defo & Byong Lee. (2016) New approaches in oral rotavirus vaccines. Critical Reviews in Microbiology 42:3, pages 495-505.
Read now
Read now
Miguel O’Ryan, Roberto Vidal, Felipe del Canto, Juan Carlos Salazar & David Montero. (2015) Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae. Human Vaccines & Immunotherapeutics 11:3, pages 584-600.
Read now
Read now
Miguel O’Ryan, Yalda Lucero, Miguel A O’Ryan-Soriano & Shai Ashkenazi. (2010) An update on management of severe acute infectious gastroenteritis in children. Expert Review of Anti-infective Therapy 8:6, pages 671-682.
Read now
Read now
Miguel O’Ryan & Alexandre C Linhares. (2009) Update on Rotarix™: an oral human rotavirus vaccine. Expert Review of Vaccines 8:12, pages 1627-1641.
Read now
Read now
P Noel Barrett, Wolfgang Mundt, Otfried Kistner & M Keith Howard. (2009) Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. Expert Review of Vaccines 8:5, pages 607-618.
Read now
Read now
Aruna Chandran & Mathuram Santosham. (2008) RotaTeq™: a three-dose oral pentavalent reassortant rotavirus vaccine. Expert Review of Vaccines 7:10, pages 1475-1480.
Read now
Read now
Lucia Helena de Oliveira, M Carolina Danovaro-Holliday, Cuauhtemoc Ruiz Matus & Jon Kim Andrus. (2008) Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Review of Vaccines 7:3, pages 345-353.
Read now
Read now
Gideon Kersten & Hoang Hirschberg. (2007) Needle-free vaccine delivery. Expert Opinion on Drug Delivery 4:5, pages 459-474.
Read now
Read now
Articles from other publishers (51)
Fausta Michael, Mariam M. Mirambo, Dafrossa Lyimo, Abdul Salehe, Furaha Kyesi, Delfina R. Msanga, Dina Mahamba, Helmut Nyawale, Elizabeth Kwiyolecha, Bernard Okamo, Paul J. Mwanyika, Victoria Maghina, Elice Bendera, Mohammed Salehe, Adolfine Hokororo, Ernestina Mwipopo, Asha C. Khamis, Honest Nyaki, Richard Magodi, Delphius Mujuni, Eveline T. Konje, Betina Katembo, Ritha Wilillo & Stephen E. Mshana. (2023) Rotavirus genotype diversity in Tanzania during Rotavirus vaccine implementation between 2013 and 2018. Scientific Reports 13:1.
Crossref
Crossref
Shazia Bashir, Rawan Fitaihi & Hend E. Abdelhakim. (2023) Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage forms. European Journal of Pharmaceutical Sciences 182, pages 106374.
Crossref
Crossref
William G. Valiant, Kang Cai & Peter M. Vallone. (2022) A history of adventitious agent contamination and the current methods to detect and remove them from pharmaceutical products. Biologicals 80, pages 6-17.
Crossref
Crossref
Zakaria Barsoum. (2021) Paediatric rotavirus gastroenteritis: A prospective study of regional prevalent genotypes, genotype correlation with disease severity and viral co-infection in County Mayo, Ireland, in the year following rotavirus vaccine introduction in Ireland. Journal of Virological Methods 294, pages 114179.
Crossref
Crossref
Remon Abu-Elyazeed, Nicola P. Klein, Leentje Moerman, Michael Povey, Anthony Pruitt, Shelly Senders, Peter Silas, Dan Bi, Armando Acevedo, Rogelio Amisola, Luke Anschutz, Regine Bataille, James Campbell, Matthew Cornish, Joseph Domachowske, John Fling, Earl Franklin, Joshua Fuller, Alvin Gabrielsen, Alan Garscadden, Giancarlo Guido, James Hedrick, David Hurley, Donald Hurley, William Johnston, Aarti Kulshrestha, Michael Leonardi, Martin Levinson, Sean Livingston, Gary Marshall, Paola Pirrotta, Walter Rok, Stephen Russell, Martin Schear, Julie Shepard, Laurent Sigg, Tina Singh, Mary Tipton, Ana Ugarte, Paul Wisman & Edward Zissman. (2021) Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine 39:10, pages 1534-1543.
Crossref
Crossref
Omkar ChaudharyLingyun WangDeepanwita BoseVivek NarayanMing Te YehAngela CarvilleJohn D. ClementsRaul AndinoPamela A. KozlowskiAnna Aldovini. (2020) Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity. AIDS Research and Human Retroviruses 36:12, pages 984-997.
Crossref
Crossref
Sang Heui Seo & Yunyueng Jang. (2020) Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection. Vaccines 8:4, pages 584.
Crossref
Crossref
Olufemi Samuel Folorunso & Olihile M. Sebolai. (2020) Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines. Vaccines 8:3, pages 341.
Crossref
Crossref
Nabil Abid, Giovanni Chillemi & Marco Salemi. (2019) Coding-Gene Coevolution Analysis of Rotavirus Proteins: A Bioinformatics and Statistical Approach. Genes 11:1, pages 28.
Crossref
Crossref
Sarah Wilmschen, Joern E. Schmitz & Janine Kimpel. (2019) Viral Vectors for the Induction of Broadly Neutralizing Antibodies against HIV. Vaccines 7:3, pages 119.
Crossref
Crossref
Eric M. Katz, Mathew D. Esona, Naga S. Betrapally, Lucia A. De La Cruz De Leon, Yenny R. Neira, Gloria J. Rey & Michael D. Bowen. (2019) Whole-gene analysis of inter-genogroup reassortant rotaviruses from the Dominican Republic: Emergence of equine-like G3 strains and evidence of their reassortment with locally-circulating strains. Virology 534, pages 114-131.
Crossref
Crossref
Karol Sestak. (2018) Non-Human Primate Models of Enteric Viral Infections. Viruses 10:10, pages 544.
Crossref
Crossref
F. Hoeksema, J. Karpilow, A. Luitjens, F. Lagerwerf, M. Havenga, M. Groothuizen, G. Gillissen, A.A.C. Lemckert, B. Jiang, R.A. Tripp & C. Yallop. (2018) Enhancing viral vaccine production using engineered knockout vero cell lines – A second look. Vaccine 36:16, pages 2093-2103.
Crossref
Crossref
Yuxian Li, Lili Guan, Xiuming Liu, Jing Yang, Xiaomei Zhang, Fawei Wang, Yongxin Guo, Haiyan Li & Xiaokun Li. (2018) Oral immunization with rotavirus VP7‑CTB fusion expressed in transgenic Arabidopsis�thaliana induces antigen‑specific IgA and IgG and passive protection in mice. Experimental and Therapeutic Medicine.
Crossref
Crossref
Sunyoung Jeong, Van Thai Than, Inseok Lim & Wonyong Kim. (2016) Differentiation of RotaTeq ® vaccine strains from wild-type strains using NSP3 gene in reverse transcription polymerase chain reaction assay. Journal of Virological Methods 237, pages 72-78.
Crossref
Crossref
Muhammad Asif Zahoor, Mohsin Khurshid, Rabia Qureshi, Aneeqa Naz & Muhammad Shahid. (2016) Cell culture-based viral vaccines: current status and future prospects. Future Virology 11:7, pages 549-562.
Crossref
Crossref
K. Zaman, Jessica A. Fleming, John C. Victor, Mohammad Yunus, Tajul Islam A. Bari, Tasnim Azim, Mustafizur Rahman, Syed Mohammad Niaz Mowla, William J. Bellini, Monica McNeal, Joseph P. Icenogle, Ben Lopman, Umesh Parashar, Margaret M. Cortese, A. Duncan Steele & Kathleen M. Neuzil. (2016) Noninterference of Rotavirus Vaccine With Measles-Rubella Vaccine at 9 Months of Age and Improvements in Antirotavirus Immunity: A Randomized Trial. Journal of Infectious Diseases 213:11, pages 1686-1693.
Crossref
Crossref
Zigang Shen, Zhiqiang Tian, Haiyang He, Ji Zhang, Jintao Li & Yuzhang Wu. (2015) Antiviral Effects of Cyclosporin A in Neonatal Mice With Rotavirus-Induced Diarrhea. Journal of Pediatric Gastroenterology & Nutrition 60:1, pages 11-17.
Crossref
Crossref
Jing Zhang, Haixia Liu, Lei Jia, Daniel C. Payne, Aron J. Hall, Ziqian Xu, Zhiyong Gao, Zhaorui Chang, Baoming Jiang, Umesh D. Parashar, Lei Meng, Hongjie Yu & Zhaojun Duan. (2015) Active, Population-based Surveillance for Rotavirus Gastroenteritis in Chinese Children. Pediatric Infectious Disease Journal 34:1, pages 40-46.
Crossref
Crossref
Allison F. Dennis, Sarah M. McDonald, Daniel C. Payne, Slavica Mijatovic-Rustempasic, Mathew D. Esona, Kathryn M. Edwards, James D. Chappell & John T. Patton. (2014) Molecular Epidemiology of Contemporary G2P[4] Human Rotaviruses Cocirculating in a Single U.S. Community: Footprints of a Globally Transitioning Genotype. Journal of Virology 88:7, pages 3789-3801.
Crossref
Crossref
Enyonam Tsolenyanu, Mapaseka Seheri, Anoumou Dagnra, Edem Djadou, Segla Tigossou, Martin Nyaga, Edotse Adjeoda, Georges Armah, Jason M. Mwenda & Yawo Atakouma. (2014) Surveillance for Rotavirus Gastroenteritis in Children Less Than 5 Years of Age in Togo. Pediatric Infectious Disease Journal 33:Supplement 1, pages S14-S18.
Crossref
Crossref
Manjari Lal, Scott Priddy, Lou Bourgeois, Richard Walker, Walt Pebley, James Brown, James Desai, Michael J. Darsley, Debra Kristensen & Dexiang Chen. (2013) Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate. Vaccine 31:42, pages 4759-4764.
Crossref
Crossref
N. Parez, B. Pozzetto, N. Texier, O. Mory, A. Garbarg-Chenon & B. Téhard. (2013) Incidence des gastroentérites à rotavirus chez les enfants de moins de cinq ans consultant un pédiatre ou un médecin généraliste en France. Pathologie Biologie 61:3, pages 99-107.
Crossref
Crossref
Andrew Duncan Steele, Kathleen M Neuzil, Nigel A Cunliffe, Shabir A Madhi, Pieter Bos, Bagrey Ngwira, Desiree Witte, Stacy Todd, Cheryl Louw, Mari Kirsten, Sanet Aspinall, Leen Jan Van Doorn, Alain Bouckenooghe, Pemmaraju V Suryakiran & Htay Htay Han. (2012) Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. BMC Infectious Diseases 12:1.
Crossref
Crossref
M. Soltani, I. Bouanene, A. Trabelsi, A. Harbi, M. Hachicha, F. Amri, S. Boussnina, M.N. Gueddiche, M.T. Sfar, N. Teleb, M. Ben Ghorbel & E. Ben Hamida. (2012) Épidémiologie des gastroentérites à rotavirus chez les enfants âgés de moins de cinq ans en Tunisie – Résultats de la surveillance sentinelle hospitalière 2009 à 2011. Revue d'Épidémiologie et de Santé Publique 60:6, pages 473-480.
Crossref
Crossref
N. Parez, O. Mory, B. Pozzetto, A. Garbag-Chenon, S. Pillet, N. Texier & B. Téhard. (2012) Impact des gastroentérites à Rotavirus chez les enfants de moins de cinq ans hospitalisés ou consultant en services d’urgences en France. Pathologie Biologie 60:5, pages 275-281.
Crossref
Crossref
A.‐M. Inka Borchers, Nuria Gonzalez‐Rabade & John C. Gray. (2012) Increased accumulation and stability of rotavirus VP6 protein in tobacco chloroplasts following changes to the 5′ untranslated region and the 5′ end of the coding region. Plant Biotechnology Journal 10:4, pages 422-434.
Crossref
Crossref
O. CASHMAN, P. J. COLLINS, G. LENNON, B. CRYAN, V. MARTELLA, S. FANNING, A. STAINES & H. O'SHEA. (2011) Molecular characterization of group A rotaviruses detected in children with gastroenteritis in Ireland in 2006–2009. Epidemiology and Infection 140:2, pages 247-259.
Crossref
Crossref
T. Vesikari, A. Karvonen, A. Bouckenooghe, P.V. Suryakiran, I. Smolenov & H.H. Han. (2011) Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants. Vaccine 29:11, pages 2079-2084.
Crossref
Crossref
Miguel L. O'Ryan, James P. Nataro & Thomas G. Cleary. 2011. Infectious Diseases of the Fetus and Newborn. Infectious Diseases of the Fetus and Newborn
359
418
.
D.M.W. Zaiss, C.J.P. Boog, W. van Eden & A.J.A.M. Sijts. (2010) Considerations in the design of vaccines that induce CD8 T cell mediated immunity. Vaccine 28:49, pages 7716-7722.
Crossref
Crossref
Carlos Rodrigo, Nuran Salman, Vladimir Tatochenko, Zsofia Mészner & Carlo Giaquinto. (2010) Recommendations for rotavirus vaccination: A worldwide perspective. Vaccine 28:31, pages 5100-5108.
Crossref
Crossref
Michael C. FlickingerJohn G. Auniņš. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology
1
35
.
M. K. Munos, C. L. F. Walker & R. E. Black. (2010) The effect of rotavirus vaccine on diarrhoea mortality. International Journal of Epidemiology 39:Supplement 1, pages i56-i62.
Crossref
Crossref
Shabir A. Madhi, Nigel A. Cunliffe, Duncan Steele, Desirée Witte, Mari Kirsten, Cheryl Louw, Bagrey Ngwira, John C. Victor, Paul H. Gillard, Brigitte B. Cheuvart, Htay H. Han & Kathleen M. Neuzil. (2010) Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants. New England Journal of Medicine 362:4, pages 289-298.
Crossref
Crossref
R. Mirzayeva, A.D. Steele, U.D. Parashar, K. Zaman, K.M. Neuzil & E.A.S. Nelson. (2009) Evaluation of rotavirus vaccines in Asia—Are there lessons to be learnt?. Vaccine 27, pages F120-F129.
Crossref
Crossref
Luan T. Le, Trang V. Nguyen, Phuong M. Nguyen, Nguyen T. Huong, Ngo T. Huong, Nguyen T.M. Huong, Tran B. Hanh, Dang N. Ha, Dang D. Anh, Jon R. Gentsch, Yuhuan Wang, Mathew D. Esona, Roger I. Glass, A. Duncan Steele, Paul E. Kilgore, Nguyen V. Man, Baoming Jiang & Nguyen D. Hien. (2009) Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. Vaccine 27, pages F130-F138.
Crossref
Crossref
Miguel L OʼRyan, German Hermosilla & Gonzalo Osorio. (2009) Rotavirus vaccines for the developing world. Current Opinion in Infectious Diseases 22:5, pages 483-489.
Crossref
Crossref
K.B. Phua, F.S. Lim, Y.L. Lau, E.A.S. Nelson, L.M. Huang, S.H. Quak, B.W. Lee, Y.L. Teoh, H. Tang, I. Boudville, L.C. Oostvogels, P.V. Suryakiran, I.V. Smolenov, H.H. Han & H.L. Bock. (2009) Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study. Vaccine 27:43, pages 5936-5941.
Crossref
Crossref
G. Chodick, O. Waisbourd-Zinman, V. Shalev, E. Kokia, M. Rabinovich & S. Ashkenazi. (2009) Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel. The European Journal of Public Health 19:3, pages 254-259.
Crossref
Crossref
KyungDong Bae, JunYoul Choi, YangSuk Jang, SangJeom Ahn & ByungKi Hur. (2009) Innovative vaccine production technologies: The evolution and value of vaccine production technologies. Archives of Pharmacal Research 32:4, pages 465-480.
Crossref
Crossref
Johannes Forster, Alfredo Guarino, Nathalie Parez, Fernando Moraga, Enriqueta Román, Olivier Mory, Alberto E. Tozzi, Ana López de Aguileta, Ulrich Wahn, Clive Graham, Reinhard Berner, Titus Ninan, Celia Barberousse, Nadia Meyer & Montse Soriano-Gabarró. (2009) Hospital-Based Surveillance to Estimate the Burden of Rotavirus Gastroenteritis Among European Children Younger Than 5 Years of Age. Pediatrics 123:3, pages e393-e400.
Crossref
Crossref
Marta Rutka & Wiesława Janaszek-Seydlitz. (2009) Szczepionki rotawirusowe – wczoraj, dziś i jutro. Pediatria Polska 84:2, pages 177-183.
Crossref
Crossref
Baoming Jiang, Jon R. Gentsch & Roger I. Glass. (2008) Inactivated rotavirus vaccines: A priority for accelerated vaccine development. Vaccine 26:52, pages 6754-6758.
Crossref
Crossref
Penelope H. Dennehy, Helen R. Bertrand, Peter E. Silas, Silvia Damaso, Leonard R. Friedland & Remon Abu-Elyazeed. (2008) Coadministration of RIX4414 Oral Human Rotavirus Vaccine Does Not Impact the Immune Response to Antigens Contained in Routine Infant Vaccines in the United States. Pediatrics 122:5, pages e1062-e1066.
Crossref
Crossref
T.P. Zomer, Y.T.H.P. van Duynhoven, M.J.J. Mangen, N.A.T. van der Maas, H. Vennema, H. Boot & H.E. de Melker. (2008) Assessing the introduction of universal rotavirus vaccination in the Netherlands. Vaccine 26:29-30, pages 3757-3764.
Crossref
Crossref
Alexandre C. Linhares & F. Raúl Velázquez. (2008) Rotavirus P[4]G2 in a Vaccinated Population, Brazil. Emerging Infectious Diseases 14:5, pages 864a-864.
Crossref
Crossref
Zsófia Mészner, Ágnes Balogh, Krisztián Bányai, József Kovács, Petr Pazdiora, Jacek Mrukowicz, Géza Molnár, Vladimir Tatochenko, Maria Avdicova & Alenka Kraigher. (2008) The Clinical Burden of Rotavirus Disease. Pediatric Infectious Disease Journal 27:1, pages S33-S41.
Crossref
Crossref
Montse Soriano-Gabarró, Thomas Verstraeten, Paul Gillard & Thomas Breuer. (2008) Potential Impact of Rotarix According to Rotavirus Type Distribution. Pediatric Infectious Disease Journal 27:1, pages S28-S32.
Crossref
Crossref
Geoffrey Davidson, Elizabeth J Elliott, Carl Kirkwood & Rodney Pearce. (2007) Preventing rotavirus gastroenteritis: Do you have the facts?. Journal of Paediatrics and Child Health 43:7-8, pages 564-567.
Crossref
Crossref
Jeffrey W. Almond. (2007) Vaccine renaissance. Nature Reviews Microbiology 5:7, pages 478-481.
Crossref
Crossref